Zai Lab Ltd — Director's Dealing 2021

Jan 4, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Zai Lab Ltd (ZLAB)
CIK: 0001704292
Period of Report: 2021-01-01

Reporting Person: Sandler Alan B. (Head of Global Dev., Oncology)

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	30000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$108.93	2030-12-01	Ordinary Shares (47000)		Direct

Footnotes

F1: The option vests in equal annual installments over five years beginning on 12/01/2021, the first anniversary of the date of grant.